Patents
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
07/2004
07/29/2004WO2004063181A1 Urea derivatives and their use as anti-inflammatory agents
07/29/2004WO2004063163A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
07/29/2004WO2004063150A2 Diagnostic and therapeutic alkyl piperidine/piperazine compounds and process
07/29/2004WO2004062601A2 Antibacterial agents
07/29/2004WO2004041162A3 Inhibitors of akt activity
07/29/2004US20040147748 Increasing insulin secretion; type II diabetes; such as 2-(3-Chloro-4-methanesulfonyl-phenyl)-3-cyclopentyl-N-(5-methylsulfanyl-pyrazin-2-yl)-propionamide
07/29/2004US20040147575 Hypotensive agents; cardiovascular disorders
07/29/2004US20040147569 Cell differentiation inducer
07/29/2004US20040147520 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
07/29/2004US20040147519 Sulfonylquinoxalone acetamide derivatives as bradykinin antagonists
07/29/2004US20040147512 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
07/29/2004US20040147454 Aspartyl protease inhibitors
07/29/2004US20040146554 Providing an active pharmaceutical compound; providing a basic salt as one of a powder, a suspension and a solution having a pH greater than 7; combining; delivering the non-enteric coated liquid formulation
07/29/2004DE10302500A1 New carboxamide derivatives useful as factor Xa or VIIa inhibitors e.g. for treating thrombosis, myocardial infarction, arteriosclerosis, inflammation, stroke and angina
07/29/2004CA2851462A1 Antibacterial agents
07/29/2004CA2512582A1 Antibacterial agents
07/29/2004CA2512257A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
07/28/2004EP1058698B1 Preparation for prevention and healing of inflammation affections
07/28/2004CN1516690A Heterocyclic derivatives and medicines
07/28/2004CN1516687A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
07/28/2004CN1515563A Aryl substituted piperazine for curing benign prostatauxe
07/28/2004CN1515556A Intermediate compound for preparing aryl substituted piperazine
07/28/2004CN1159303C Preparation of intermediate for monocyclic beta-lactams antibiotic derivatives
07/27/2004CA2103861C Novel 7-(substituted)-8-(substituted-9-(substituted amino)-6-demethyl-6-deoxytetracyclines
07/22/2004WO2004060308A2 Thiosemicarbazones as anti-virals and immunopotentiators
07/22/2004US20040143123 zirconium complexes of bis(o-hydroxybenzylamines); further reaction of dicarbonyls such as methyl (2S)-5-chloro-2,3-dihydro-2-hydroxy-1-oxo-1H-indene-2-carboxylate with protected hydrazine and N-(XC(O))-N-methoxycarbonyl-p-(trifluoromethyl)aniline
07/22/2004US20040143117 serine/threonine kinase inhibitors; 2,3-diphenylquinoxalines in which at least one of the phenyls is substituted with an amine group, particularly 2-[4-(2-aminoprop-2-yl)phenyl]-3-phenylquinoxaline; treating cancer
07/22/2004US20040143018 Thrombosis; emphysema; antihistamines; cirrhosis; antiarthritic agents; anticancer agenst
07/22/2004US20040142993 Viricides
07/22/2004US20040142989 Viricides
07/22/2004US20040142878 N-cycloalkylglycines as HIV protease inhibitors
07/22/2004US20040142206 substituted with aromatic groups, e.g., 2,2'-dihexyloxy-6,6'dianthracenyl- (or 6,6'-dipyrenyl-) 1,1'-binaphthylene; good solubility in common organic solvents, resist crystallization and can be sublimed in a device fabrication process.
07/22/2004CA2511646A1 Thiosemicarbazones as anti-virals and immunopotentiators
07/21/2004EP1439169A1 DIFLUOROALKENE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE SAME, AND INTERMEDIATE THEREFOR
07/21/2004EP1438302A1 New sulfonamide derivatives as d3-receptor agonists
07/21/2004EP1438298A1 Piperazine derivatives with ccr1 receptor antagonist activity
07/21/2004EP1438292A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
07/21/2004EP0757685B1 Novel acyclic and cyclic amides as neurotransmitter release enhancers
07/21/2004CN1513846A Method of preparing 2,5-dimethyl pyrazine using gas solid contact catalytic process
07/21/2004CN1513845A Separation and purification method of 2,5-dimethyl pyrazine
07/21/2004CN1158264C Metabotropic glutamate receptor antagonists for treating central nervous system disease
07/21/2004CN1158245C Iron alkali salt of S,S-ethylenediamine-n,n'-disuccinic acid, and process for producing same
07/15/2004WO2004058755A2 Compound libraries of imidazo[1,5-a]pyridin-3-yl derivatives and related heterobicycles for targetting compounds capable of binding to g-protein coupled receptors
07/15/2004WO2004058735A2 Ligands of melanocortin receptors and compositions and methods related thereto
07/15/2004WO2004058720A2 Compound libraries of 1,3,5-substitute indazole derivatives as compounds for targetting compounds capable of binding to the g-protein coupled receptor
07/15/2004WO2004058705A2 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor
07/15/2004WO2004058265A1 Compound libraries of 2,3-substituted pyrazine derivatives capable of binding to g-protein coupled receptors
07/15/2004WO2004058264A1 Compound libraries of 2h-spiro (isoquinoline-1, -piperidine derivatives and related compounds for targetting compounds capable of binding to the g-protein receptor
07/15/2004WO2004058263A1 Compound libraries of 2, 3, 4, 9-tetrahydrospiro (beta-carboline-1, 4 -piperidine) derivatives and related compounds for targetting compounds capable of binding to the g-protein receptor
07/15/2004WO2004058259A1 Compound libraries of n-(aminocarbonyl)-piperidine-4-carboxamide derivatives capable of binding to g-protein coupled receptors
07/15/2004WO2004048345A3 2,5-diketopiperazines for the treatment of obesity
07/15/2004WO2004046092A3 Aryl sulfonamides
07/15/2004WO2004039780A8 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds
07/15/2004WO2004039753A3 Phenyl compounds
07/15/2004WO2003075836A3 Cathepsin cysteine protease inhibitors
07/15/2004US20040138228 Novel compounds with analgesic effect
07/15/2004US20040138206 Novel sulfonamide derivatives, intermidiate thereof, its preparation methods, and pharmaceutical composition comprising the same
07/14/2004EP1437346A1 Benzamide derivatives useful as cell differentiation inducers
07/14/2004EP1436271A1 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
07/14/2004EP1436249A2 Muscarinic agonists
07/14/2004EP1435934A1 5'-acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
07/14/2004EP1435782A1 Treatment for cystic fibrosis
07/14/2004EP1282595B1 Novel phenyl-propargylether derivatives
07/14/2004EP1144368B1 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
07/14/2004CN1512988A Pyrimidine, Triazine and pyrazine derivatives as glutamate receptors
07/14/2004CN1157382C New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents cnotaining these compounds
07/13/2004US6762321 Amide compounds and use thereof
07/13/2004US6762226 Photostability; heat and oxidation resistance
07/13/2004US6762205 Phenyl sulfamate derivatives
07/13/2004US6762187 Heterocyclic nitrogen compounds used as enzyme inhibitors for prophylaxis of human immunodeficiency virus(hiv)
07/08/2004WO2004056774A2 Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
07/08/2004WO2004056751A1 Antibacterial agents
07/08/2004WO2004056727A2 Process of making chalcone derivatives
07/08/2004WO2004009017A3 Modulators of the glucocorticoid receptor and method
07/08/2004WO2003103599A3 Caspase-1 inhibitors and methods for their use
07/08/2004US20040132785 Thiolesters and uses thereof
07/08/2004US20040132782 Aspartyl protease inhibitors
07/08/2004US20040132758 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders
07/08/2004US20040132744 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications.
07/08/2004US20040132718 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
07/08/2004US20040132618 Therapeutic amides
07/08/2004US20040131544 Positron emission tomography ; multistage process; medical diagnosis
07/08/2004CA2510471A1 Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
07/07/2004EP1435352A2 9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines
07/07/2004EP1434583A1 N-aroyl piperazine derivatives as orexin receptor antagonists
07/07/2004EP1434580A2 Allylamides useful in the treatment of alzheimer's disease
07/07/2004EP1218359B1 Piperazine compounds as tachykinins antagonists
07/06/2004US6759549 Method of preparing amino carboxylic acids
07/06/2004US6759428 Indole nitriles
07/06/2004US6759412 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis
07/01/2004WO2004055009A1 Novel compounds having selective inhibiting efect at gsk3
07/01/2004WO2004055006A1 Novel compounds having selective inhibiting effect at gsk3
07/01/2004WO2004024878A3 Structurally rigid dopamine d3 receptor selective ligands and process for making them
07/01/2004WO2003093297A3 Protein kinase modulators and methods of use
07/01/2004WO2003080577A3 Amidoacetonitrile compounds
07/01/2004CA2508045A1 Novel compounds having selective inhibiting efect at gsk3
06/2004
06/30/2004EP1432687A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
06/30/2004EP0746555B1 High temperature epoxy resins
06/30/2004CN1508132A HO-EPCP synthesizing method
06/30/2004CN1155581C Process for preparing 5-methylpyrazine-2-carboxylic acid